http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5484806-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-32 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-32 |
| filingDate | 1995-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1996-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_394b98a0b1217de1b0f7554c76c04228 |
| publicationDate | 1996-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5484806-A |
| titleOfInvention | Phospholipase A2 inhibitors |
| abstract | There are disclosed compounds of the formula: <IMAGE> wherein R1 is hydrogen, alkyl, cycloalkyl, arylalkyl, -(CH2)rCH=CH2, -(CH2)sOY, -(CH2)tCH(OZ)CH3, or Ar; X is O, S, or NR2; Y and Z are each, independently, hydrogen, alkyl, or -COR3; R2 and R3 are each, independently, hydrogen, alkyl, or arylalkyl; Ar is an aryl radical that may be optionally substituted; m=1-5; n=0-1; p=1-9; r=0-6; s=2-6; and t=0-6 or a pharmaceutically acceptable salt thereof which are useful as antiinflammatory agents. |
| priorityDate | 1994-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 260.